Providing next-generation precision delivery platform
Addressing the biggest global unmet clinical needs in tissue regeneration
Renovos offers a step change in precision regenerative medicine and therapeutics delivery with an exciting new nanoclay platform
Renovos offers a step change in precision regenerative medicine and therapeutics delivery with an exciting new nanoclay platform
The Need for New Approaches
Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. New regenerative approaches are desperately needed.
Our Mission
We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective tissue regeneration, offering safer, more economic solutions for health systems, and better outcomes for patients, to help them remain active for longer.
The Science
Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which hosts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at reduced doses for safer and more efficient applications.
RENOVITE®
delivery platform
Revolutionary platform technology, RENOVITE®, uses synthetic nanoclay to safely and precisely deliver therapeutic agents for regenerative medicine and beyond.
Transforming Patient Lives
Regenerative medicine holds the promise of improving the healing process and therefore relieving pain and returning patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives, for both active living and healthy ageing.
The Need for New Approaches
Welcome increase in life expectancy has led to a rise in age-related diseases and healthcare costs. In addition to the ageing world population, increasingly active younger demographics are also prone to trauma, injury or disease. New regenerative approaches are desperately needed.
Our Mission
We are pioneering a nanoclay gel technology platform, RENOVITE®, for medical applications to address the unmet need for effective tissue regeneration, offering safer, more economic solutions for health systems, and better outcomes for patients, to help them remain active for longer.
The Science
Our proprietary platform technology, RENOVITE®, acts as injectable scaffold which hosts regenerative cells and templates new tissue formation. It localises and retains delivered biologics, allowing their use at reduced doses for safer and more efficient applications.
synthetic nanoclay therapeutic delivery platform
Transforming Patient Lives
Regenerative medicine – the use of stem cell and material technologies – holds the promise of improving the healing process and therefore relieves pain and returns patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives, for both active living and healthy ageing.
Partnering Opportunities
Our RENOVITE® nanoclay technology has been refined and developed over years of academic research, innovation, rigorous testing and validation.
Renovos welcomes enquiries from potential partners that might wish to utilise our RENOVITE® nanoclay in their own therapeutics, biologics or device development programmes.
